Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01318408Phase 4Completed
Phase 4, open-label trial of levetiracetam in epilepsy, sponsored by Drexel University. Primary endpoints: Mini-Mental State Examination at 12 weeks and Alzheimer's Disease Assessment Scale-Cognitive Subscale at 12 weeks. Started Nov 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01318408.